Penserra Capital Management LLC Raises Stake in HCA Healthcare, Inc. (NYSE:HCA)

Penserra Capital Management LLC boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 147.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,320 shares of the company's stock after purchasing an additional 1,979 shares during the quarter. Penserra Capital Management LLC's holdings in HCA Healthcare were worth $1,146,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC bought a new position in HCA Healthcare during the fourth quarter valued at $1,021,000. Proficio Capital Partners LLC boosted its holdings in shares of HCA Healthcare by 45.5% in the fourth quarter. Proficio Capital Partners LLC now owns 745 shares of the company's stock valued at $223,000 after purchasing an additional 233 shares during the period. Larson Financial Group LLC increased its holdings in HCA Healthcare by 7.9% during the fourth quarter. Larson Financial Group LLC now owns 725 shares of the company's stock valued at $218,000 after buying an additional 53 shares during the period. Simplicity Wealth LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $229,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of HCA Healthcare by 12.1% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 102,638 shares of the company's stock worth $30,807,000 after acquiring an additional 11,067 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

NYSE HCA traded up $0.67 during trading hours on Wednesday, hitting $378.27. 1,217,743 shares of the company's stock traded hands, compared to its average volume of 1,460,980. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a market capitalization of $91.00 billion, a PE ratio of 16.82, a PEG ratio of 1.31 and a beta of 1.47. The firm's 50-day moving average is $373.21 and its 200-day moving average is $340.45. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. During the same period in the prior year, the firm posted $5.36 earnings per share. The firm's quarterly revenue was up 5.7% on a year-over-year basis. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio is currently 12.81%.

Insider Transactions at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on HCA shares. Guggenheim initiated coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating on the stock. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their price target for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Stephens raised HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Robert W. Baird restated a "neutral" rating and issued a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Finally, Barclays set a $416.00 price objective on shares of HCA Healthcare and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Seven analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average price target of $395.71.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.